GSK applies for world’s first Malaria Vaccine for regulatory approval

July 24, 2014 5:31 PM

17 0

Africa – The regulatory approval of world’s first vaccine against malaria in children has been applied by GlaxoSmithKline (NASDAQ:GSK) on Thursday. This will be evaluated by European Medicine Agency (EMA) in association with World Health Organisation. This vaccine has been named as a shot, RTS, S.

Malaria is a mosquito borne disease caused by protozoa known as plasmodium. They are of three species, P. Malaria, P. Vivax and P. Falciparum. Out of these three, P. Falciparum is considered to be the most fatal one. This disease cause infection in the blood, leading to the three cycles of symptoms ...

Read more

To category page